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Background: The direct role for p38 MAPK in foam cell formation has not been investigated.
Results: Inhibition and activation of p38 MAPK alter levels of autophagy activity and cholesterol ester accumulation in
macrophages.
Conclusion: p38 MAPK promotes cholesterol ester accumulation and foam cell formation through inhibition of autophagy.
Significance: Results from this study provide brand new understanding of the role for p38 MAPK in the development of
atherosclerosis.
p38 MAPK has been strongly implicated in the development
of atherosclerosis, but its role in cholesterol ester accumulation
inmacrophages and formation of foam cells, an early step in the
development of atherosclerosis, has not been investigated. We
addressed this issue and made some brand new observations.
First, elevated intracellular cholesterol level induced by the
exposure to LDL-activated p38 MAPK and activation of p38
MAPKwith anisomycin increased the ratio of cholesterol esters
over free cholesterol, whereas inhibition of p38 MAPK with
SB203580 or siRNA reduced the LDL loading-induced intracel-
lular accumulation of free cholesterol and cholesterol esters in
macrophages. Second, exposure to LDL cholesterol inhibited
autophagy in macrophages, and inhibition of autophagy with
3-methyladenine increased intracellular accumulation of cho-
lesterol (free cholesterol and cholesterol esters), whereas activa-
tion of autophagy with rapamycin decreased intracellular accu-
mulation of free cholesterol and cholesterol esters induced by
the exposure to LDL cholesterol. Third, LDL cholesterol load-
ing-induced inhibition of autophagy was prevented by blockade
of p38 MAPK with SB203580 or siRNA. Neutral cholesterol
ester hydrolase was co-localized with autophagosomes. Finally,
LDL cholesterol loading and p38 activation suppressed expres-
sion of the key autophagy gene, ulk1, inmacrophages. Together,
our results provide brand new insight about cholesterol ester
accumulation in macrophages and foam cell formation.
Accumulation of free cholesterol and cholesterol esters in
monocytes/macrophages is an essential step in the develop-
ment of foam cells and atherosclerotic plaques (1, 2). Free cho-
lesterol can go through plasma membrane through either dif-
fusion or transporter (ABCA1, ABCG1, and Apo-E)-mediated
efflux (2, 3). Thus, the accumulation of cholesterol esters (free
cholesterol  free fatty acids) in macrophages is necessary for
foam cell formation. Cholesterol ester accumulation is mainly
balanced by two independent processes: conversion of free cho-
lesterol into cholesterol esters by acyl-CoA-cholesterol trans-
ferase 1 (ACAT1) and degradation of cholesterol esters into
free cholesterol and free fatty acids by the neutral cholesterol
ester hydrolase (CEH)2 (2–6). It is known that overexpression
of CEH cloned by Ghosh et al. (2, 4) in macrophage alone can
degrade cholesterol esters and reduce foam cell formation and
atherosclerosis. The diet-induced atherosclerosis is increased
in ApoE/ mice when the cholesterol ester hydrolase
(nCEH1/nCEH) cloned by Ishibashi et al. (7) is knocked out.
However, regulation of the cholesterol ester hydrolase-medi-
ated degradation of cholesterol esters remains unestablished
currently.
Macroautophagy (referred to as “autophagy” hereafter) is an
essential process of breaking down macromolecules and aged/
damaged cellular organelles for providing a fuel source ormain-
taining cellular health (8, 9). Autophagy has been shown to be
activated in advanced (late stage) atherosclerotic plaques by
many (10, 11). Both protective and detrimental effects of
autophagy have been described in atherosclerosis (10, 11).
However, the potential role of autophagy in the formation of
foam cells from macrophages, an early event in the develop-
ment of atherosclerosis, has not been established. It has
recently been shown that autophagy is required for breaking
down triglyceride into glycerol and free fatty acids in hepato-
cytes and adipocytes (12, 13) and involved in cholesterol efflux
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frommacrophages (14). It is noteworthy that triglyceride (glyc-
erol free fatty acids) and cholesterol esters (free cholesterol
free fatty acids) are both a form of fat storage and share similar
components. It is currently unknown whether or not degrada-
tion of cholesterol esters also depends on autophagy.
p38MAPK has been strongly implicated in the development
of atherosclerosis. It can promote atherosclerosis in many dif-
ferent ways. For example, p38MAPK can stimulate secretion of
MCP-1 and IL-8, which attractmonocytes to vascular endothe-
lial cells (15–22). p38 MAPK mediates the MCP-1-dependent
transendothelialmigration, integrin activation, and chemotaxis
(23–26). p38MAPK promotes differentiation of humanmono-
cytes intomacrophages (27), inhibits proliferation while induc-
ing apoptosis of endothelial cells (28–30), stimulates endothe-
lial migration (30), down-regulates endothelial progenitor cells
(31), and accelerates endothelial progenitor cell senescence
(32). p38 MAPK can be activated in monocytes/macrophages,
vascular endothelial cells, and vascular smoothmuscle cells by a
variety of stimulants, including reactive oxygen species (18, 29);
high level of glucose (21, 28, 32); chylomicron remnants (19);
free fatty acids (33); cholesterol (34); proinflammatory cyto-
kines, such as TNF- (35); and growth factors, such as PDGF
(36–39). Finally, it is known that p38 MAPK can inhibit
autophagy (40). Nevertheless, it is currently unknown whether
or not p38MAPK inhibition of autophagy is involved in choles-
terol ester accumulationwithinmacrophages and foamcell for-
mation, an early event in the development of atherosclerosis. In
this study, we investigated the potential roles of p38MAPK and
autophagy in cholesterol ester accumulation in macrophages
and defined the relationship between p38 MAPK and
autophagy in the process.
MATERIALS AND METHODS
Reagents and Antibodies—THP-1 cells were obtained from
the American Type Culture Collection (ATCC). Primary
human CD14 monocytes were obtained from Sanguine (cat-
alog no. PBMC-005a). Low density lipoproteins (LDLs), aniso-
mycin, SB203580, rapamycin, and 3-methyladenine were from
Sigma. GFP-LC3-expressing plasmids (pEGFP-LC3) were kind
gifts from Dr. Tamotsu Yoshimori (Osaka University, Osaka,
Japan). Antibodies against LC3, phosphorylated p38 MAPK,
totalp38MAPK,Ulk1,phospho-Ulk1Ser-317, phospho-Ulk1Ser-757,
or LAMP-1 were fromCell Signaling Technologies Inc. (Bev-
erly, MA). Antibody against neutral cholesterol ester hydro-
lase 1 (nCEH1) was from Sigma (catalog no. HPA026888).
Antibodies against -actin, mouse IgG, and rabbit IgG were
obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA). BODIPY493/503 and the Amplex Red cholesterol assay
kit were obtained from Invitrogen. The apoptosis assay kit
was from Roche Applied Science (catalog no. 11774425001).
Other materials were all obtained commercially and are of
analytical quality.
Cell Cultures—The human THP-1 cell line was obtained
from theATCC andmaintained in RPMI 1640medium supple-
mented with 10% fetal calf serum, 2 mM L-glutamine, penicillin
(100 units/ml), and streptomycin (100 g/ml) (Invitrogen).
THP-1 cells were cultured at 37 °C, 100%humidity, and 5%CO2
at 5  105 cells/ml density. Primary human CD14 monocytes
were cultured in RPMI 1640 supplemented with 10% heat-in-
activated fetal calf serum (FCS), 2 mM L-glutamine, 100 IU/ml
penicillin, and 100mg/ml streptomycin at a density of 1–2mil-
lion cells/ml.
Immunoblotting—THP-1 cells (5  105/ml) were pretreated
with 1640mediumwith PMA (100ng/ml) for 3 days, stimulated
as noted in the figures for 24 h, and then lysed on ice for 30min
in 35 l of lysis buffer (20 mM Tris, pH 7.4, 150 mMNaCl, 1 mM
EDTA, 1%Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate,
1 mM sodium orthovanadate, 1 mM sodium fluoride, 1 mM
PMSF, and proteinase inhibitor mixture (Roche Applied Sci-
ence)). Cell debris was pelleted by centrifugation, and superna-
tants were collected and stored at 80 °C until assayed. Thirty
micrograms of total cellular proteinwere denatured at 95 °C for
5min in the loading buffer (60mMTris, 2.5% SDS, 10% glycerol,
5%mercaptoethanol, 0.01% bromphenol blue) and subjected to
10% SDS-PAGE. For detection of LC3I and -II, the 16% SDS-
PAGE straight gels were used. Proteins in the gels were trans-
ferred to PVDF membranes and blocked with TBS containing
0.05% Tween 20 (TBS-T) and 5% nonfat milk powder for 1 h.
After being washed in TBS-T, membranes were probed with
specific antibodies (1:1000) overnight at 4 °C and were then
washed with TBS-T and incubated with a polyclonal secondary
goat anti-rabbit antibody or rabbit anti-mouse antibody
(1:5000; Santa Cruz Biotechnology, Inc.) for 1 h at room tem-
perature. Following three washes in TBS-T, membranes were
incubated with the ECF substrate solution (GE Healthcare)
according to the manufacturer’s protocol (Thermo Scientific).
Fluorescent bands were visualized with a Molecular Imager
VersaDoc MP 4000 System (Bio-Rad) and quantified by using
densitometry analyses with ImageQuant version 5.2 software
from GE Healthcare.
Immunoprecipitation—Cytosolic extracts (1000 g) were
used to perform immunoprecipitation assays according to the
manufacturer’s instructions (Pierce). Rabbit polyclonal anti-
LC3b or rabbit IgG (10 g/sample) was used for immunopre-
cipitating nCEH overnight at 4 °C. Resins (Pierce) were added
then, and the samples were agitated for an additional 2 h at 4 °C
and centrifuged at 1000  g for 1 min at 4 °C six times. The
resulting pellets were washed three times with lysis buffer
(Pierce), suspended in 5 sample buffer, andheated to 95 °C for
5 min. The resulting mixtures were subjected to immunoblot-
ting as described above with rabbit monoclonal antibody
against nCEH as the primary antibodies and goat anti-rabbit
IgG as the secondary antibodies. LC3b or IgG was detected as
loading control.
Transfection—THP-1 cells (2  105 cells in 12-well plates)
were transiently transfected with 2 g of purified recombinant
plasmid, pEGFP-LC3, using LipofectamineTM 2000 (Invitro-
gen) overnight in Opti-MEM medium following the manufac-
turer’s instructions. Before they were treated, THP-1 cells were
maintained in RPMI 1640 medium, supplemented with 10%
fetal calf serum, 2 mM L-glutamine, penicillin (100 units/ml),
and streptomycin (100 g/ml) (Invitrogen). THP-1 cells were
cultured at 37 °C, 100% humidity, and 5% CO2 at 5  105
cells/ml density.
Measurement of Cholesterol—After cells were treated as
noted, cells were washed with PBS at room temperature three
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times. Cells were scraped off in ice-old lysis buffer (18mMTris-
HCl, 300 mM mannitol, 50 mM EGTA, pH 7.6, with protease
inhibitors). The cell suspension was sonicated for 10 1-s pulses
with a microtip. Lipid was extracted from cells by using a
method described by Folch et al. (41). Briefly, methanol (2 ml)
and chloroform (4ml) were added into cell lysate andmixed by
vortex, followed by a 2-h violent shaking. KCl (0.8 ml, 0.15 M)
was added and mixed by vortex. These mixtures were centri-
fuged for 5min at 750 r.p.m (3000 g) for the phase separation.
The top aqueous phase was removed with a Pasteur pipette.
The bottom phase (organic solvent) was evaporated under vac-
uum to achieve lipid pellet. Isopropyl alcohol with 10% Triton
X-100 was used to dissolve lipids (100–200l in total) contain-
ing cholesterol methyl ether. Total and free cholesterol was
quantified with the Amplex Red cholesterol assay kit in a
96-well format. Meanwhile, protein levels in the same samples
were measured as a normalization standard.
Fluorescence Microscopy—For fluorescence microscopy,
THP-1 cells and primary human CD14 monocytes were cul-
tured on microscopic coverglasses in 12-well plates overnight
and were then treated as noted for 24 h. After the noted treat-
ments, cells were fixed with 4% paraformaldehyde in PBS for 15
min. All of the cellular images were obtained using an inverted
Nikon Eclipse 200 fluorescence microscope. For quantification
of autophagic cells, GFP-LC3 punctated dots were determined
from triplicates by counting a total of more than 60 cells.
HumanCD14monocytes were fixed in 4% paraformaldehyde,
blocked/permeabilized in 2.5% BSA, 0.1% Triton X-100 for 1 h
at room temperature, and stained with the LAMP-1 primary
antibodies overnight at 4 °C. Fluorophore-conjugated second-
ary antibodies were incubated in the presence of BODIPY493/
503 (0.1 M) to stain neutral lipids at room temperature. Apo-
ptotic cell death was determined by nuclear staining with
Hoechst 33342 (5 g/ml) for fragmented and condensed nuclei
for 15 min followed by fluorescence microscopy.
Introduction of Small Interfering RNA (siRNA)—THP-1 cells
were transiently transfected with 100 nM siRNA against p38
MAPK (Santa Cruz Biotechnology, Inc.) with Lipofectamine
2000 transfection reagents (Invitrogen) according to instruc-
tions from the manufacturer. Transfection mixtures were
added to cells in Opti-MEM medium for 16 h before media
were replaced with the regular RPMI 1640 medium supple-
mented with 10% FBS.
Oil Red O Staining—THP-1 cells were cultured at an initial
density of 2  105 cells/well in 12-well plates and treated with
the noted reagents for 24 h. Cells were then washed three times
with cold PBS and fixed with 4% paraformaldehyde for 30 min.
Cells were then washed three times with cold PBS and stained
with the Oil Red O solution (0.5 g of Oil Red O powder dis-
solved in 60% ethanol) for 15 min at room temperature. Cells
were subsequently washed again with PBS to remove the
unbound dye and visualized by using a light microscopy.
RESULTS
Cholesterol Loading with LDL Activates p38 MAPK in
Macrophages—To examine the effect of the exposure to a high
level of cholesterol on p38 MAPK activity, primary human
CD14 monocytes were incubated with LDL aggregates for a
different time (1, 3, 6, 12, or 24 h) as described previously (42) or
for 24 h with a different amount of LDL aggregates (10–50
g/ml), followed by evaluations of total and phosphorylated
p38 MAPK as we described previously (43–47). As shown in
Fig. 1, exposure to LDL stimulated phosphorylation of p38
MAPK in a time- and dose-dependent manner. Similar results
were observed in human THP-1 macrophages (data not
shown).
Activation of p38 MAPK Is Associated with Increased Accu-
mulation of Cholesterol Esters in Macrophages Exposed to
LDL—To determine the role of p38 MAPK activation in cho-
lesterol accumulation, activity of p38 MAPK was either stimu-
lated or inhibited inTHP-1macrophages thatwere treatedwith
LDL as noted, followed by visualization of cholesterol accumu-
lation inmacrophageswithOil RedO staining. As shown in Fig.
2A, lipid droplets were significantly increased in macrophages
exposed to LDL.Treatmentwith anisomycin, a p38MAPKacti-
vator, alone increased the accumulation of lipid droplets and
further enhanced the LDL-mediated accumulation of lipid
droplets in macrophages. In contrast, treatment with
SB203580, a specific inhibitor of p38 MAPK, completely pre-
vented the LDL-mediated accumulation of lipid droplets (Fig.
2A). Similarly, inhibition of p38MAPKwith siRNA against p38
MAPK prevented the LDL-induced accumulation of lipid
droplets, whereas the scrambled siRNAhad no effect. To deter-
mine the components of the accumulated lipid droplets, levels
of free cholesterol or cholesterol esters in themacrophages that
were similarly treated as described in the legend to Fig. 2Awere
quantified. As shown in Fig. 2B, levels of both free cholesterol
and cholesterol esters were increased by the exposure to LDL in
macrophages. Treatment with LDL together with p38 MAPK
activator, anisomycin, significantly increased the level of cho-
lesterol esters while decreasing the level of free cholesterol in
macrophages. As a result, the ratio of cholesterol esters over
free cholesterol was dramatically increased by anisomycin (Fig.
2B). Treatment of macrophages with anisomycin alone mainly
increased the level of free cholesterol (Fig. 2B). This was prob-
FIGURE 1. Cholesterol loading with LDL activates p38 MAPK in human
CD14 monocytes. Primary Human CD14 monocytes were incubated with
LDL aggregates with for a different time (1, 3, 6, 12, or 24 h) (A) or for 24 h with
different amounts of LDL aggregates (10 –50 g/ml) (B), followed by evalua-
tions of total and phosphorylated p38 MAPK as indicated (n  3) by using
immunoblotting with specific antibodies. Levels of -actin in the same blots
were measured by immunoblotting. Levels of phosphorylated p38 MAPK
(P-p38) and total p38 MAPK (T-p38) were quantified by densitometry and
normalized to -actin. Results were presented as mean  S.E. (error bars) of
three independent experiments. **, p  0.01 versus control.
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ably caused by the reduced efflux of free cholesterol from
macrophages by activation of p38 MAPK because it has previ-
ously been shown that p38 MAPK can inhibit the ABCG1-de-
pendent efflux of free cholesterol (48). Incubation of macro-
phages with LDL together with p38 MAPK inhibitor,
SB203580, decreased the level of total cholesterol and the ratio
between cholesterol esters over free cholesterol (Fig. 2B). Incu-
bation ofmacrophageswith SB203580 alone decreased the level
of total cholesterol and the cholesterol esters/free cholesterol
ratio (Fig. 2B). Similarly, knockdown of the p38 MAPK gene
with the specific siRNAdecreased the ratio of cholesterol esters
over free cholesterol in the presence or absence of LDL (Fig.
2B). As shown in Fig. 2, C and D, p38 MAPK phosphorylation
was stimulated by the exposure to LDL and further enhanced by
anisomycin butwas inhibited by SB203580 in themacrophages.
It should be noted that treatment with anisomycin did not
cause obvious apoptosis (supplemental Fig. 1). Together, these
results indicate that activation of p38 MAPK promotes choles-
terol ester accumulation, whereas inhibition of p38 MAPK
decreases cholesterol ester accumulation in macrophages.
Modulation of Autophagy Activity Can Alter Accumulation
of Cholesterol Esters Induced by Exposure to LDL in
Macrophages—To examine the effect of autophagy in choles-
terol accumulation in macrophages, autophagy activity in
human THP-1 macrophages was either stimulated with rapa-
mycin, an inhibitor of mTOR, or inhibited by using 3-methy-
ladenine, an inhibitor of autophagy. As shown in Fig. 3A, lipid
accumulation was increased by the exposure to LDL, but the
increase was prevented by rapamycin. In contrast, inhibition of
autophagy with 3-methyladenine enhanced the basal or the
LDL-induced lipid accumulation. Levels of both free choles-
terol and cholesterol esters were increased by the exposure to
LDL (Fig. 3B). Stimulation of autophagy with rapamycin
decreased the LDL-induced accumulation of cholesterol and
cholesterol esters (Fig. 3B). The cholesterol esters/cholesterol
ratio was also significantly decreased by rapamycin (Fig. 3B).
Rapamycin alone did not alter the level of total cholesterol but
decreased the cholesterol esters/cholesterol ratio significantly
(Fig. 3B). In contrast, inhibition of autophagy with 3-methylad-
enine increased both total level of cholesterol and the ratio of
cholesterol esters/cholesterol in macrophages that were either
treated with LDL or not (Fig. 3B). Together, these results show
that autophagy plays an important role in determining the
accumulation of cholesterol and cholesterol esters in
macrophages.
Exposure to LDL Inhibits Autophagy in Macrophages—To
examine the effect of exposure to LDLon autophagy, autophagy
activity was examined in THP-1 macrophages in two different
methods: measurements of LC3II-LC3I ratio and visualization
ofGFP-labeled autophagosomes. As shown in Fig. 4A, exposure
to LDL decreased the ratio of LC3II/LC3I. Treatment with
rapamycin increased the LC3II/LC3I ratio, whereas 3-methy-
ladenine decreased the LC3II/LC3I ratio. Similarly, exposure of
macrophages to LDL decreased the GFP-labeled autophago-
somes (Fig. 4B). Treatment with rapamycin increased autopha-
FIGURE 2. Accumulation of cholesterol esters induced by cholesterol loading with LDL in macrophages is p38 MAPK-dependent. A, THP-1 cells were
treated by using the vehicle solution, LDL (25 g/ml), LDL plus anisomycin (Ani; a p38 MAPK activator, 10 M), anisomycin alone, LDL plus SB203580 (SB) (a p38
MAPK inhibitor, 10 M), SB203580 alone, LDL plus siRNA against p38 MAPK (siRNA), siRNA against p38 MAPK alone, or scrambled siRNA (ScrRNA) for 24 h as
indicated (n  3). Lipid droplets were visualized by using Oil Red O staining (magnification 10). B, levels of free cholesterols and cholesterol esters were
evaluated by using the Amplex Red cholesterol assay kit in the THP-1 cells similarly treated as described in A. Results were presented as mean  S.E. of three
independent experiments, each in triplicate. , p  0.05 versus free cholesterol in control; , p  0.01 versus free cholesterol in control; ##, p  0.01 versus
free cholesterol in cells loaded with LDL; *, p  0.05 versus cholesterol esters in control; **, p  0.01 versus cholesterol esters in control; $$, p  0.01 versus
cholesterol esters in cells treated with LDL (one-way ANOVA with Scheffe’s post hoc test). C and D, levels of phosphorylated and total p38 MAPK and -actin in
the cells described in A and B were detected by using immunoblotting with specific antibodies and quantified. Results represent mean  S.E. (error bars) of
three independent experiments. **, p  0.01 versus control; ##, p  0.01 versus LDL alone (one-way ANOVA with Scheffe’s post hoc test).
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gosomes, whereas 3-methyladenine decreased autophago-
somes in macrophages (Fig. 4B).
p38 MAPK Mediates LDL-induced Inhibition of Autophagy
inMacrophages—To determine the role of p38MAPK in LDL-
induced inhibition of autophagy, activators and inhibitors of
p38 MAPK were applied. As shown in Fig. 5A, exposure of
THP-1 macrophages to LDL decreased the LC3-GFP-labeled
autophagosomes. Activation of p38MAPK with anisomycin
also reduced the LC3-GFP-labeled autophagosomes. In con-
trast, inhibition of p38 MAPK with either a chemical
(SB203580; SB) or siRNA against p38MAPK increased LC3II-
GFP-labeled autophagosomes in the presence or absence of
LDL (Fig. 5A). To determine the connection between
autophagy and cholesterol ester degradation, immunoprecipi-
tation assays were applied with antibodies against LC3, nCEH,
or species-specific IgG. As shown in Fig. 5B, LDL loading
decreased the co-localization of LC3 and nCEH, but inhibition
of p38 MAPK with SB203580 increased the co-localization of
LC3 and nCEH. Together, these results demonstrate that
autophagosomes co-localize with nCEH, and the LDL-induced
inhibition of autophagy is mediated by p38 MAPK.
Localization of Neutral Lipids and Lysosomes—Because the
autophagy-mediated degradation of macromolecules has to go
through lysosomes and autophagolysosomes (49), we
attempted to localize the lipid droplets and lysosomes by stain-
ing neutral lipids with fluorescent dye BODIPY493/503 and
lysosomes with antibodies against the marker protein of lyso-
somes, LAMP-1, as described (14). As shown in supplemental
Fig. 2, the level of neutral lipids was increased, whereas the
number of lysosomes was reduced by the treatment with LDL
aggregates or anisomycin. Most lipid droplets were not co-lo-
calized with lysosomes. In contrast, inhibition of p38 MAPK
with SB203580 decreased the number of lipid droplets while
increasing the number of lysosomes. Inhibition of p38 MAPK
with SB203580 increased themerging of lipid droplets and lyso-
somes. Together, these results indicate that p38 MAPK plays a
critical role in regulating accumulation of neutral lipids in
macrophages through the lysosome/autophagolysosome-me-
diated degradation of neutral lipids.
p38 MAPK Mediates LDL Cholesterol Loading-inhibited
Expression of Key Autophagy Gene, ulk1, in Macrophages—To
investigate the mechanism by which LDL cholesterol loading
and p38 MAPK inhibit autophagy in macrophages, the effects
of LDL cholesterol loading and p38MAPK on phosphorylation
and expression of ulk1, the key autophagy initiation gene, were
examined. As shown in Fig. 6, LDL loading did not alter Ulk1
phosphorylation but obviously decreased Ulk1 protein level
and the LC3II/LC3I ratio. Activation of p38MAPK with aniso-
mycin also decreased expression of Ulk1 and the LC3II/LC3I
FIGURE 3. Accumulation of cholesterol esters induced by cholesterol
loading with LDL in macrophages is regulated by autophagy. A, THP-1
cells were treated by using the vehicle solution, LDL (25 g/ml), LDL plus
rapamycin (Rap) (an autophagy activator, 10 M), rapamycin alone, LDL plus
3-methyladenine (3-MA; an autophagy inhibitor, 10 M), or 3-methyladenine
alone for 24 h as indicated (n  3). Lipid droplets were visualized with Oil Red
O staining (magnification 10). B, levels of free cholesterol and cholesterol
esters in similarly treated cells were quantified by using the Amplex Red cho-
lesterol assay kit. Results were presented as mean  S.E. (error bars) of three
independent experiments, each in triplicate. *, p  0.05 versus free cholesterol
in control; #, p  0.05 versus cells treated with LDL alone; , p  0.05 versus
cholesterol esters in control; $$, p  0.01 versus cholesterol esters in cells
treated with LDL alone (one-way ANOVA with Scheffe’s post hoc test).
FIGURE 4. Cholesterol loading with LDL inhibits autophagy in macro-
phages. A, THP-1 cells were treated with either the vehicle solution or LDL (25
g/ml) in the presence of rapamycin (Rap; 10 M) or 3-methyladenine (3MA;
10 M), rapamycin alone, or 3-methyladenine alone as indicated for 24 h (n 
3). Levels of LC3II and -I were detected by using immunoblotting with specific
antibodies and quantified by using densitometry analysis. The ratio of the
LC3II/LC3I band was subsequently calculated. -Actin in the same samples
was detected by immunoblotting. **, p  0.01 versus control. ##, p  0.01
versus LDL alone (one-way ANOVA). B, GFP-tagged LC3 was introduced into
THP-1 cells via transient transfection overnight prior to the treatment with
LDL, rapamycin, and 3-methyladenine similarly as described in A. The GFP-
tagged LC3 dots were visualized by a fluorescence microscope (magnifica-
tion 40) and quantified in at least 20 cells/group and presented as mean 
S.E. (error bars) of three independent experiments. **, p  0.01 versus control;
##, p  0.01 versus LDL alone (one-way ANOVA).
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ratio in the presence or absence of LDL loading. In contrast,
inhibition of p38 MAPK with either SB203580 or specific
siRNA against p38 MAPK increased expression of Ulk1 and
the LC3II/LC3I ratio in the presence or absence of LDL loading.
Together, these results indicate that LDL cholesterol loading
inhibits autophagy and expression of the key autophagy gene
(ulk1) in a p38 MAPK-dependent manner.
DISCUSSION
p38MAPK has been strongly implicated in the development
of atherosclerosis (50). However, its direct role in foam cell
formation, an early event in the development of atherosclerosis,
has not been investigated.We addressed this issue in this study
and made several key findings.
First, p38MAPK regulates the level of cholesterol ester accu-
mulation in macrophages. Cholesterol ester accumulation in
macrophages is an essential step of foam cell formation and
development of atherosclerosis. The level of cholesterol esters
in vascular macrophages is determined by the conversion of
free cholesterol and fatty acids into cholesterol esters catalyzed
by ACAT1 and the degradation of cholesterol esters back to
free cholesterol and fatty acids catalyzed by cholesterol ester
hydrolase. Transgenic overexpression of cholesterol ester
hydrolase has been shown to prevent/reduce atherosclerosis (2,
4). Although p38 MAPK has been shown to be involved in the
development of atherosclerosis in many different ways, its
direct role in foam cell formation has not been described. For
the first time, we show here that cholesterol loading via LDL
can activate p38 MAPK, and activation of p38 MAPK is
involved in elevated accumulation of cholesterol esters in
macrophages (Figs. 1 and 2). This finding will provide a more
specific target to prevent and reverse foam cell formation and
atherosclerosis through p38 MAPK.
Second, autophagy regulates the level of cholesterol ester
accumulation in macrophages. Autophagy is a housekeeping
process to maintain cellular health by removing aged/damaged
FIGURE 5. The LDL-induced inhibition of autophagy is p38 MAPK-dependent in macrophages. A, GFP-LC3 was introduced into THP-1 cells via transient
transfection overnight prior to treatments with LDL (25 g/ml), anisomycin (Ani; 10 M), SB203580 (SB; 10 M), siRNA against p38 MAPK (siRNA), or scrambled
siRNA (ScrRNA) for 24 h (n  3). The GFP-LC3 dots were visualized by a fluorescence microscope (magnification 40) and quantified. B, THP-1 cells were treated
with LDL (25 g/ml) in the presence or absence of SB203580 for 24 h prior to the immunoprecipitation (IP) assays. Antibodies against LC3b were used to
precipitate nCEH, followed by detection of nCEH in the precipitates with antibodies against either nCEH or LC3. As a control, nonspecific IgG was used to
precipitate nCEH. The ratio of precipitated nCEH over LC3b was quantified and presented as mean  S.E. of three independent experiments. *, p  0.05 versus
control; **, p  0.01 versus control; ##, p  0.01 versus LDL alone.
FIGURE 6. LDL cholesterol loading and p38 MAPK inhibits expression of
the key autophagy initiation gene, ulk1, in macrophages. A and B, THP-1
cells were treated with LDL (25 g/ml) in the presence or absence of aniso-
mycin (Ani; 10 M), SB203590 (SB; 10 M), or siRNA against p38 MAPK as
noted for 24 h. Levels of phosphorylated Ulk1 (Ulk1Ser-317 and Ulk1Ser-757),
total Ulk1, LC3I/LC3II, and -actin were detected by using immunoblotting
with specific antibodies. Levels of LC3II, LC3I, and Ulk1 were quantified. The
LC3II/LC3I ratio and Ulk1/-actin ratio were subsequently calculated. Results
were presented as mean  S.E. (error bars) of three independent experiments.
*, p  0.05 versus control. **, p  0.01 versus control; , p  0.05 versus control;
, p  0.01 versus control; ##, p  0.01 versus LDL alone; $$, p  0.01 versus
LDL alone.
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large and long living molecules and cellular organelles (11, 51).
Its activation may be required for maintaining the health of
vascular wall cells. That may be why some studies have shown
that autophagy is protective against development of atheroscle-
rosis (10, 11). However, some have suggested that overactiva-
tion of autophagy may destabilize existing atherosclerotic
plaques, leading to acute cardiovascular events (10, 11). A
recent study has shown that autophagy regulates cholesterol
efflux from macrophage foam cells via lysosomal acid lipase
(14). However, the direct role for autophagy in cholesterol ester
accumulation in macrophages, foam cell formation, and ather-
osclerosis has not been established. Results from this study
clearly show that activation of autophagy can reduce levels of
total cholesterol and cholesterol esters inmacrophages exposed
to LDL cholesterol, whereas inhibition of autophagy can
increase intracellular accumulation of total cholesterol and
cholesterol esters in macrophages (Figs. 3 and 4). Furthermore,
our results show that the enzyme that degrades cholesterol
esters, nCEH, is co-localized with autophagosomes (Fig. 5). To
our knowledge, this is the first evidence showing that the
nCEH-mediated degradation of cholesterol esters involves
autophagy and will provide new andmore effective methods to
prevent and reverse atherosclerosis through modulating
autophagy.
Third, p38 MAPK regulates cholesterol ester accumulation
in macrophages through autophagy. Atherosclerosis is consid-
ered an inflammatory disorder of the arterial intima (11). It is
well known that p38MAPK can activate the inflammatory pro-
gram through various mechanisms, and inflammation in turn
can also activate p38MAPK (50). Thus, p38MAPK and inflam-
mation are inseparable, and the cause and effect relationship
between them is not established. It is noteworthy that increased
intracellular cholesterol level can activate p38MAPK inmacro-
phages as shown in this study. Activation of p38 MAPK then
leads to increased accumulation of cholesterol esters in macro-
phages. Therefore, it appears that activation of p38MAPKplays
a critical role in cholesterol ester accumulation inmacrophages
and formation of foam cells, an early step in the development of
atherosclerosis no matter whether p38 MAPK is activated by
either cytokines or elevated intracellular cholesterol level. It has
previously shown that p38 MAPK can inhibit autophagy in
hepatocytes (40). In this study, we show that activation of p38
MAPK leads to inhibition of autophagy in macrophages, prob-
ably via inhibition of the key autophagy gene, ulk1 (Figs. 5 and
6). Most importantly, LDL cholesterol loading-induced choles-
terol ester accumulation and inhibition of autophagy inmacro-
phages are p38MAPK-dependent. All of these observations are
brand new and provide a deeper level of understanding about
mechanisms of foam cell formation and atherosclerosis. There-
fore, results from this study will provide new and more specific
targets to prevent and treat atherosclerosis and its many asso-
ciated major health problems.
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